InTest Q3 Blowout: Record Orders and Margin Surge Challenge Bearish Thesis

What happened

InTest reported Q3 2026 results that sharply exceed prior expectations, with record orders of $49.4 million, EPS of $0.15, revenue growth of 34%, and gross margin of 47.7%. The orders figure is more than 70% above Q2's $28.9 million and far surpasses the $30 million threshold that the previous analysis flagged as a positive trigger. The gross margin rebound from 40.5% to 47.7% suggests a favorable mix shift, likely toward higher-margin semiconductor test equipment, reversing the prior quarter's margin compression. However, the press release is management's own framing, and the results may still be lumpy or driven by one or two large orders, as customer concentration has historically been high. The improved demand should support a backlog rebuild above $50 million, but investors should confirm breadth across Semi and non-semi markets in the 10-Q before treating this as a durable inflection.

Implication

Short-term, the stock is likely to rally on these results as they beat the cautious baseline, but investors should resist chasing if the move pushes the stock above $16.50, where the prior analysis suggested trimming. The record orders and margin recovery address two key concerns: weak order replenishment and deteriorating gross margin, moving the risk-reward from wait toward buy on weakness. However, the sustainability of these results depends on whether orders came from broad-based demand or from a concentrated large project, which could revert next quarter. If the 10-Q confirms orders were diversified and backlog rose above $50 million, the base-case valuation could move above $14.50, but if it was a one-off, the stock may give back gains. Patient investors should wait for a pullback toward the $13-14 area or confirmation of a second consecutive quarter of strong orders before adding.

Thesis delta

The previous WAIT thesis relied on the view that orders were not replenishing backlog and margin was weak; this report directly contradicts that, showing record orders and margin expansion, which shifts the risk-reward more positive. The semi recovery appears to be translating into order-led demand, but the magnitude suggests possible lumpiness, so we upgrade conviction from WAIT to a cautious BUY-on-weakness. The key variable now is whether this order strength is repeatable and broad-based, not just a single large deal.